Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Isopropyl iodide | HCID 6362 | — |
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | HCID 20434888 | HCID 20434888 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 20434880 | HCID 20434880 | — |
Reaction Steps
A stirred solution of 1-(6,7-dimethoxyquinazolin-4-yl)-4-[(1,1-dioxotetrahydro-1,2,6-thiadiazin-2-yl)methyl]piperidine 1/2 CH3CH2OCOCH3 (0.7 g) (prepared as in Example 9) in dimethylformamide (4.0 cm3) was treated at room temperature with sodium hydride (100 mg. of a 50% dispersion in oil) and the mixture was stirred for 45 minutes. Isopropyl iodide (255 mg) was then added and the resulting mixture was stirred for 6 hours. The solvent was removed in vacuo and the residue was taken into chloroform (50 cm3) and water (25 cm3). The aqueous phase was extracted with chloroform (2×20 cm3) and the dried (MgSO4) extracts were evaporated to yield an oil which was chromatographed on silica (Merck 60.9385) eluting with chloroform to give a gum. Crystallisation from ethyl acetate afforded 1-(6,7-dimethoxyquinazolin-4-yl)-4-([1,1-dioxo-6-isopropyltetrahydro-1,2,6-thiadiazin-2-yl]methyl)piperidine, m.p. 158°-161° (460 mg).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04489075 |
|---|
| Source dataset | uspto-grants-1984_12 |
|---|
| ORD ID | ord-4cfbbe9b8397425f9cf1240321102095 |
|---|
| Source note | uspto-grants-1984_12 |
|---|